SCHEMBL23044978

SCHEMBL23044978

[2H]C([2H])([2H])NC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)nn(C3CCCCO3)c2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 16/20 0.51
FGFR1 P11362 6/20 0.51
FLT1 P17948 3/20 0.51
FLT4 P35916 3/20 0.51
PLK4 O00444 2/20 0.51
AURKA O14965 2/20 0.51
MAP4K4 O95819 2/20 0.51
PAK4 O96013 2/20 0.51
ABL1 P00519 2/20 0.51
LCK P06239 2/20 0.51
CSF1R P07333 2/20 0.51
RET P07949 2/20 0.51
MET P08581 2/20 0.51
PDGFRB P09619 2/20 0.51
KIT P10721 2/20 0.51
PDGFRA P16234 2/20 0.51
FGFR3 P22607 2/20 0.51
TYK2 P29597 2/20 0.51
AXL P30530 2/20 0.51
BLK P51451 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13446211 0.95 KDR (0.57) KDRFGFR1FLT1FLT4PLK4
SCHEMBL18186761 0.95 KDR (0.57) KDRFGFR1FLT1FLT4PLK4
SCHEMBL30585616 0.95 KDR (0.57) KDRFGFR1FLT1FLT4PLK4
SCHEMBL23045074 0.93 KDR (0.58) KDRFGFR1FLT1FLT4PLK4
SCHEMBL30585618 0.93 KDR (0.58) KDRFGFR1FLT1FLT4PLK4
SCHEMBL30628346 0.88 KDR (0.47) KDRFGFR1FLT1FLT4PLK4
SCHEMBL14067299 0.87 KDR (0.47) KDRFGFR1FLT1FLT4PLK4
SCHEMBL14076848 0.87 KDR (0.53) KDRFGFR1FLT1FLT4PLK4
SCHEMBL31475205 0.85 KDR (0.46) KDRFGFR1FLT1FLT4PLK4
SCHEMBL4058955 0.85 KDR (0.47) KDRFGFR1FLT1FLT4PLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112442009-A Deuterated compounds and their use for treating cancer 润佳(苏州)医药科技有限公司 2021-03-05 CN claimed
WO-2021037198-A1 DEUTERATED COMPOUND AND USE THEREOF IN CANCER TREATMENT 润佳(苏州)医药科技有限公司 2021-03-04 WO claimed
CN-112442009-A Deuterated compounds and their use for treating cancer 润佳(苏州)医药科技有限公司 2021-03-05 CN disclosed